Nicholas J. Maragakis, MD; Jeffrey D. Rothstein, MD, PhD (2001;58:365-370.). "Glutamate Transporters in Neurologic Disease"Arquivado em 23 de março de 2012, no Wayback Machine.. Neurology. archneur.ama-assn.orgArquivado em 23 de março de 2012, no Wayback Machine.. Retrieved 2010-11-10. "Glutamate is the primary excitatory amino acid neurotransmitter in the human brain. It is important in synaptic plasticity, learning, and development. Its activity at the synaptic cleft is carefully balanced by receptor inactivation and glutamate reuptake. When this balance is upset, excess glutamate can itself become neurotoxic.... This overactivation leads to an enzymatic cascade of events ultimately resulting in cell death."
curiouscook.com
curiouscook.com McGee, Harold, On Food and Cooking, the Science and Lore of the Kitchen, 2004
Ball P, Woodward D, Beard T, Shoobridge A, Ferrier M (2002). «Calcium diglutamate improves taste characteristics of lower-salt soup». Eur J Clin Nutr. 56 (6): 519-523. PMID12032651. doi:10.1038/sj.ejcn.1601343 !CS1 manut: Nomes múltiplos: lista de autores (link)
Freeman, M (2006). «Reconsidering the effects of monosodium glutamate: A literature review». Journal of the American Academy of Nurse Practicioners. 18 (10): 482-486. PMID16999713. doi:10.1111/j.1745-7599.2006.00160.x
Tarasoff L., Kelly M.F. (1993). «Monosodium L-glutamate: a double-blind study and review». Food Chem. Toxicol. 31 (12): 1019-1035. PMID8282275. doi:10.1016/0278-6915(93)90012-N
Walker R (1999). «The significance of excursions above the ADI. Case study: monosodium glutamate». Regul. Toxicol. Pharmacol. 30 (2 Pt 2): S119-S121. PMID10597625. doi:10.1006/rtph.1999.1337
Willams, A. N., and Woessner, K.M. (2009). «Monosodium glutamate 'allergy': menace or myth?». Clinical & Experimental Allergy. 39 (5): 640-646. doi:10.1111/j.1365-2222.2009.03221.x !CS1 manut: Nomes múltiplos: lista de autores (link)
Shi, Z; Luscombe-Marsh, ND; Wittert, GA; Yuan, B; Dai, Y; Pan, X; Taylor, AW (2010). «Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: Findings from the Jiangsu Nutrition Study of Chinese adults». The British journal of nutrition. 104 (3): 457-63. PMID20370941. doi:10.1017/S0007114510000760 !CS1 manut: Nomes múltiplos: lista de autores (link)
Ball P, Woodward D, Beard T, Shoobridge A, Ferrier M (2002). «Calcium diglutamate improves taste characteristics of lower-salt soup». Eur J Clin Nutr. 56 (6): 519-523. PMID12032651. doi:10.1038/sj.ejcn.1601343 !CS1 manut: Nomes múltiplos: lista de autores (link)
Walker R, Lupien JR (2000). «The safety evaluation of monosodium glutamate». Journal of Nutrition. 130 (4S Suppl): 1049S-1052S. PMID10736380
Freeman, M (2006). «Reconsidering the effects of monosodium glutamate: A literature review». Journal of the American Academy of Nurse Practicioners. 18 (10): 482-486. PMID16999713. doi:10.1111/j.1745-7599.2006.00160.x
Raiten DJ, Talbot JM, Fisher KD (1996). «Executive Summary from the Report: Analysis of Adverse Reactions to Monosodium Glutamate (MSG)». Journal of Nutrition. 126 (6): 1743-1745. PMID7472671 !CS1 manut: Nomes múltiplos: lista de autores (link)
Tarasoff L., Kelly M.F. (1993). «Monosodium L-glutamate: a double-blind study and review». Food Chem. Toxicol. 31 (12): 1019-1035. PMID8282275. doi:10.1016/0278-6915(93)90012-N
Walker R (1999). «The significance of excursions above the ADI. Case study: monosodium glutamate». Regul. Toxicol. Pharmacol. 30 (2 Pt 2): S119-S121. PMID10597625. doi:10.1006/rtph.1999.1337
Shi, Z; Luscombe-Marsh, ND; Wittert, GA; Yuan, B; Dai, Y; Pan, X; Taylor, AW (2010). «Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: Findings from the Jiangsu Nutrition Study of Chinese adults». The British journal of nutrition. 104 (3): 457-63. PMID20370941. doi:10.1017/S0007114510000760 !CS1 manut: Nomes múltiplos: lista de autores (link)
Stevenson, D. D. (2000). «Monosodium glutamate and asthma». J. Nutr. 130 (4S Suppl): 1067S-1073S. PMID10736384
Nicholas J. Maragakis, MD; Jeffrey D. Rothstein, MD, PhD (2001;58:365-370.). "Glutamate Transporters in Neurologic Disease"Arquivado em 23 de março de 2012, no Wayback Machine.. Neurology. archneur.ama-assn.orgArquivado em 23 de março de 2012, no Wayback Machine.. Retrieved 2010-11-10. "Glutamate is the primary excitatory amino acid neurotransmitter in the human brain. It is important in synaptic plasticity, learning, and development. Its activity at the synaptic cleft is carefully balanced by receptor inactivation and glutamate reuptake. When this balance is upset, excess glutamate can itself become neurotoxic.... This overactivation leads to an enzymatic cascade of events ultimately resulting in cell death."